Acnecide Gel 5%
- Name:
Acnecide Gel 5%
- Company:
Galderma International S.A.S. c/o Galderma (U.K) Ltd.
- Active Ingredients:
- Legal Category:
Supply through pharmacy only
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 20/09/17
(Click to Download)XPIL
PACKAGE LEAFLET: INFORMATION FOR THE USER
PACKAGE LEAFLET: INFORMATION FOR THE USER
1. What Acnecide is and what it is used for
1. What Acnecide is and what it is used for
2. What you need to know before you use Acnecide
2. What you need to know before you use Acnecide
3. How to use Acnecide
3. How to use Acnecide
4. Possible side effects
4. Possible side effects
5. How to store Acnecide
5. How to store Acnecide
6. Contents of the pack and other information
6. Contents of the pack and other information
Summary of Product Characteristics last updated on medicines.ie: 9/2/2020
Click on this link to Download PDF directly
Galderma International S.A.S. c/o Galderma (U.K) Ltd.
 Ltd.jpg)
Company Products
| Medicine Name | Active Ingredients |
|---|---|
| Medicine Name Acnecide Gel 5% | Active Ingredients Benzoyl Peroxide, hydrous |
| Medicine Name Azzalure | Active Ingredients Botulinum Toxin Type A |
| Medicine Name Curanail 5% w/v Medicated Nail Lacquer | Active Ingredients Amorolfine Hydrochloride |
| Medicine Name Differin Cream 0.1% w/w | Active Ingredients Adapalene |
| Medicine Name Differin Gel | Active Ingredients Adapalene |
| Medicine Name Efracea capsules | Active Ingredients Doxycycline monohydrate |
| Medicine Name Epiduo 0.1%/2.5% Gel | Active Ingredients Adapalene, Benzoyl Peroxide |
| Medicine Name Etrivex 500 micrograms/g Shampoo | Active Ingredients Clobetasol Propionate |
| Medicine Name Loceryl Nail Lacquer | Active Ingredients Amorolfine Hydrochloride |
| Medicine Name Metvix Cream | Active Ingredients Methyl Aminolevulinate Hydrochloride |
| Medicine Name Mirvaso 3mg/g Gel | Active Ingredients brimonidine tartrate |
| Medicine Name Rozex Cream | Active Ingredients Metronidazole |
| Medicine Name Rozex Gel | Active Ingredients Metronidazole |
| Medicine Name Silkis Ointment | Active Ingredients Calcitriol |
| Medicine Name Soolantra 10 mg/g Cream | Active Ingredients Ivermectin |
| Medicine Name Tetralysal 300 Capsules | Active Ingredients Lymecycline |
Items Per Page :
1 - 0 of 16 items.Total: Infinity pages
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 9 February 2020 SPC
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 8 - Marketing authorisation number(s)
- File format updated to PDF
Legal category: Supply through pharmacy only
Updated on 21 September 2017 SPC
Reasons for updating
- New SPC for new product
Legal category: Supply through pharmacy only
Updated on 21 September 2017 SPC
Reasons for updating
- Change to section 4.2 - Posology and method of administration
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.6 - Pregnancy and lactation
- Change to Section 4.8 – Undesirable effects - how to report a side effect
- Change to section 4.9 - Overdose
- Change to section 5.3 - Preclinical safety data
- Change to section 10 - Date of revision of the text
Legal category: Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Section 4.2 - Update to method of administration
Section 4.3 - QRD change
Section 4.4 - Addition of warning regarding swelling/blistering of the skin
Section 4.6 - Restructuring/Rewording of the section
Section 4.8 - Addition of ADRs regarding allergic reactions
Section 4.9 - Restructuring/rewording of the section
Section 5.3 - Restructuring/Rewording of the section
Section 10 - Updated revision date
Section 4.3 - QRD change
Section 4.4 - Addition of warning regarding swelling/blistering of the skin
Section 4.6 - Restructuring/Rewording of the section
Section 4.8 - Addition of ADRs regarding allergic reactions
Section 4.9 - Restructuring/rewording of the section
Section 5.3 - Restructuring/Rewording of the section
Section 10 - Updated revision date
Updated on 20 September 2017 PIL
Reasons for updating
- New PIL for new product
Updated on 20 September 2017 PIL
Reasons for updating
- Change to section 2 - what you need to know - contraindications
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - pregnancy, breast feeding and fertility
- Change to section 3 - dose and frequency
- Change to section 3 - how to take/use
- Change to section 4 - how to report a side effect
- Change to section 6 - date of revision
Updated on 8 April 2015 PIL
Reasons for updating
- Product/presentation re-marketed
Updated on 10 October 2013 PIL
Reasons for updating
- Change to further information section
Updated on 9 September 2013 SPC
Reasons for updating
- Change to section 3 - Pharmaceutical form
- Change to section 10 - Date of revision of the text
Legal category: Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
In section 3 (pharmaceutical form), off-white has been added to the apprearance of the gel.
Updated on 13 June 2011 PIL
Reasons for updating
- Introduction of new pack/pack size
Updated on 3 June 2011 SPC
Reasons for updating
- Change to section 6.5 - Nature and contents of container
Legal category: Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Addition of 30g pack size.
Updated on 1 April 2011 PIL
Reasons for updating
- Change to side-effects
Updated on 4 March 2011 SPC
Reasons for updating
- Change to section 6.3 - Shelf life
Legal category: Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
The shelf life of the product has been reduced from 36 months to 24 months.
Updated on 2 February 2011 SPC
Reasons for updating
- Change to section 4.8 - Undesirable effects
Legal category: Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
The adverse events listed in section 4.8 have been presented in a table accroding to system organ class and frequency of occurence. Some additional adverse events have also been added to the table in section 4.8.
Updated on 9 July 2009 PIL
Reasons for updating
- Change due to user-testing of patient information
Updated on 25 February 2008 SPC
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
Legal category: Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Update to section 4.4 - Special Warnings and Special Precautions for Use
Updated on 19 March 2007 PIL
Reasons for updating
- Addition of marketing authorisation holder
Updated on 30 August 2006 SPC
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 10 - Date of revision of the text
Legal category: Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Section 7 Change of office address from Galderma House, Church Lane, Kings Langley, Herts, WD4 8 JP to Meridien House, 69-71 Clarendon Road, Watford, Herts, WD17 1DS
Updated on 16 May 2005 PIL
Reasons for updating
- New PIL for medicines.ie
Updated on 16 June 2003 SPC
Reasons for updating
- New SPC for medicines.ie
Legal category: Supply through pharmacy only